MRI-guided radiation therapy for endometrial cancer after surgery
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests a new way of giving radiation therapy after surgery for endometrial cancer. It uses MRI scans to guide the radiation, which may help target the treatment more precisely and reduce side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older.
- You have had surgery (hysterectomy) for endometrial cancer, and your doctor recommends radiation therapy after surgery.
- You have certain types or stages of endometrial cancer, such as stage IB grade 3, stage II, or stage IIIA-C1 endometrioid, or certain other types like clear cell or carcinosarcoma.
- If you are getting chemotherapy or other systemic therapy, it will not be given at the same time as the radiation.
- You are able to have an MRI scan and lie still for 45-60 minutes without severe claustrophobia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using MRI scans daily during pelvic radiation therapy improves treatment precision and outcomes for endometrial cancer patients who need radiation after surgery. The goal is to better target cancer while reducing side effects.
This study tests a shorter, more intense course of radiation therapy after surgery for endometrial cancer. It aims to see if it is safe and works as well as standard radiation, while possibly reducing treatment time.
This trial tests a precise type of radiation (stereotactic radiotherapy) given after surgery for endometrial cancer. It aims to improve treatment while reducing side effects.
This trial compares two types of radiation therapy (a newer technique called MH-ART versus a standard technique called CF-IMRT) given after surgery for cervical or endometrial cancer. The goal is to see which approach works better and causes fewer side effects.
This trial studies a new type of radiation therapy (called online adaptive radiotherapy) given in shorter, higher daily doses after surgery for high-risk endometrial cancer. The goal is to see if this approach is safe and effective for reducing side effects while still controlling the cancer.
This trial tests whether radiation therapy after surgery is safe and effective for early-stage endometrial cancer. It is designed for patients with certain molecular subtypes and who have not had chemotherapy.
Hear when a new Endometrial Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.